Research
Gene ‘switched off’ in early stages of pancreatic cancer, allowing rapid tumour growth and spread
The findings of a research project that we part-funded from Nottingham Trent University has now been announced, with researchers discovering that pancreatic cancer is able to 'switch off' a gene which enables it to become more aggressive.
How we’re striving for better treatments
Thanks to our generous supporters, we’ve invested £14.4 million in research into the early detection and treatment of pancreatic cancer to date.
Our research projects
Pancreatic Cancer UK Discovery and Translational Research Forum, 20 & 21 May 2024
New vaccine shows promise at preventing pancreatic cancer recurrence
A trial of a new vaccine which could prevent recurrence of pancreatic cancer following surgery has shown promising results.
Research Innovation Fund
Find out more about the Pancreatic Cancer UK Research Innovation Fund and how you can apply.
NHS publishes first ever Long Term Workforce Plan
Our Director of Research, Support and Influencing comments on the first ever Long Term Workforce Plan published by the NHS.
Help shape our research
Ground-breaking research into new treatment for pancreatic cancer underway in Scotland
Pioneering research into a new potentially ground-breaking treatment for pancreatic cancer has begun. The research, lead by University of Glasgow scientist Dr Seth Coffelt, aims to help make desperately needed new immunotherapy treatments a reality for future patients.
World-first pancreatic cancer breath test
We’re thrilled to announce that we are funding a new clinical study to develop a breath test that could detect pancreatic cancer early enough to save thousands of lives a year.
Four things we’ve learnt about early detection
Our researchers have laid the vital groundwork for the development of new tests for the early detection of pancreatic cancer. Here we take a look at what they have achieved so far.